Continuous treatment with an effective anti-inflammatory has disease-modifying properties in axSpA INTRODUCTION Spondyloarthritis (often shortened to SpA) is an umbrella term for several conditions that share many features and symptoms. These conditions include ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Spondyloarthritis can be classified as axial or non-axial (peripheral), according to which joints in the […]
Category: Spondyloarthritis
Fully vaccinated people with systemic rheumatic diseases have less severe COVID outcomes
Breakthrough COVID-19 had lower hospitalisation and mortality in vaccinated patients INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours to try to limit […]
Full vaccination course is necessary for efficient response
People with inflammatory arthritis may have impaired response to the first dose but excellent final responses to mRNA vaccines. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced […]
First study to show inflammatory arthritis can affect male fertility
Men diagnosed with inflammatory arthritis before and during the peak of reproductive age have lower fertility. INTRODUCTION Inflammatory arthritis is a group of diseases including spondyloarthritis, rheumatoid arthritis, and psoriatic arthritis. These are chronic inflammatory diseases that affects a person’s joints, and may cause pain and disability. Inflammatory arthritis can affect people before or during […]
Higher inflammatory burden than previously anticipated
Axial inflammation seen in people with early peripheral spondyloarthritis, but not predictive of relapse in those achieving remission. INTRODUCTION Spondyloarthritis (shortened to SpA) refers to a spectrum of related rheumatic diseases caused by chronic inflammation. Many people with spondyloarthritis also have non-joint symptoms, such as psoriasis of the skin and nails, inflammatory bowel disease and […]
IL-17- or TNF inhibitors have comparable efficacy after failure of previous TNF inhibitors
Symptom relief and time on therapy are similar for people taking TNF inhibitors or secukinumab after previous TNF inhibitor failure. INTRODUCTION Spondyloarthritis (often shortened to SpA) is an umbrella term for several conditions that share many features and symptoms. These conditions include ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Spondyloarthritis can be classified as axial […]
Work is more affected for people in rural areas
Geography plays a role in health and work outcomes. INTRODUCTION Spondyloarthritis (often shortened to SpA) is an umbrella term for several conditions that share many features and symptoms. These conditions include ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Spondyloarthritis can be classified as axial or non-axial (peripheral), according to which regions in the body are […]
Individual- and country-level health inequalities exist in people with SpA
After taking other factors into account, women and people with lower levels of education have worse disease activity. Introduction Spondyloarthritis (often shortened to SpA) is an umbrella term for several conditions that share many features and symptoms. Thesec onditions include ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Spondyloarthritis can be classified as axial or non […]
Managing axial spondyloarthritis
This is the lay version of the EULAR recommendations for the management of people with axial spondyloarthritis. The original publication can be downloaded from the EULAR website: www.eular.org. van der Heijde D, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017;76:978–991. doi:10.1136/annrheumdis-2016-210770 Introduction EULAR recommendations give advice to […]
Even patients with well-controlled disease can have high levels of fear
The FAIR questionnaire could be useful both in routine doctor visits and clinical trials to identify a person’s fear levels about their disease and its treatment INTRODUCTION Rheumatoid arthritis is a chronic (long-term) inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common […]
